Atlas Trials

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

Clinical trial NCT01149655 · COMPLETED

Trial details

NCT number
NCT01149655
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-07-01
Primary completion
2013-11-01
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.